Revamping R&E Tax Strategies with the One Big Beautiful Bill Act
The realm of Research and Experimental (R&E) expenditures represents a keystone in propelling innovation across diverse sectors. Traditionally, tax legislation has leveraged these costs as a catalyst for innovation by sanctioning their deduction, thus lowering taxable income for businesses.
The landmark One Big Beautiful Bill Act (OBBBA), enacted on July 4, 2025, marks a pivotal shift by permanently reinstating the immediate deduction for domestic R&E expenditures. This reverses contentious alterations introduced by the Tax Cuts and Jobs Act (TCJA) of 2017. With this legislation, emerging under the auspices of Internal Revenue Code Section 174A, returns a vital inducement for U.S.-based innovation. However, it enforces stringent capitalization mandates for foreign R&E initiatives.
Defining R&E Expenses R&E outlays, typically known as R&D (Research and Development) costs, encompass expenses related to the conception or enhancement of products, including software development. These generally embrace:
Salaries for employees participating in research tasks.
Materials and supplies utilized in research activities.
Expenditures on third-party researchers.
Overhead costs linked to facilities and equipment supporting R&E functions, encompassing rent, utilities, insurance, and maintenance.
The IRS often defines these expenditures with broad latitude to foster a diverse array of inventive pursuits.
A Brief History of R&E Expensing Prior to the TCJA amendments, effective for tax years initiating post-December 31, 2021, businesses had the discretion under prior Section 174 to either instantly deduct R&E expenditures in the year incurred or to capitalize and amortize them over 60-month durations. This was particularly advantageous for innovation-driven firms in terms of cash flow.
The TCJA amendments, commencing in 2022, abolished this choice, necessitating the capitalization and subsequent five-year amortization of all R&E expenses for domestic research, and a 15-year period for foreign research. This engendered considerable tax cash-flow pressures for nascent firms and startups that, despite pre-revenue status, were undertaking substantial R&D endeavors, resulting in protracted deduction timelines instead of immediate tax relief.
R&E Expensing Post-OBBBA Effective for tax years starting post-December 31, 2024, the OBBBA, through new Section 174A, reshapes the approach to domestic R&E.
Distinction Between Domestic and Foreign Expenditures The OBBBA establishes a notable contrast based on the geographical locus of research undertakings:
Domestic R&E Expenditures: Taxpayers are now empowered to fully and immediately deduct the entirety of these expenses in the payment or incurrence year. This reinstates the favorable pre-2022 stance, incentivizing research within the U.S. Nevertheless, taxpayers still hold the option to capitalize and amortize over at least 60 months if preferred.
Foreign R&E Expenditures: The 15-year amortization requirement persists unchanged under OBBBA for research executed outside the U.S. The Act explicitly precludes immediate recovery of any unamortized basis in foreign R&E upon property disposition or abandonment post-May 12, 2025. This variance is anticipated to prompt multinational enterprises to reassess their research site strategies to optimize tax benefits.
Options to Accelerate Currently Amortizing Expenses The OBBBA allows for significant transitional relief concerning the R&E costs capitalized from 2022-2024 under preceding TCJA regulations. Taxpayers with unamortized domestic R&E costs from this epoch may hasten their deductions beginning the first tax year post-December 31, 2024 (commonly, the 2025 tax year):
Option 1: Full Expensing in 2025: Deduct the entire unamortized domestic R&E balance in the initial tax year post-December 31, 2024.
Option 2: Two-Year Amortization: Claim deductions for the unamortized balance evenly over two years (50% in the 2025 tax year and 50% in the 2026 tax year).
Option 3: Ongoing Amortization: Taxpayers may elect to proceed with the remaining original five-year amortization schedule.
Eligible Small Businesses: For qualifying small businesses (characteristically those with an average annual gross receipt of $31 million or less over the prior three tax years), an enhanced option exists:
o Retroactive Expensing via Amended Returns: These entities can opt to retrospectively apply full expensing rules to tax years starting post-December 31, 2021, by lodging amended returns (e.g., for 2022, 2023, and 2024 tax years) to recoup taxes remitted under former regulations. This option must be leveraged by July 4, 2026, and entails synchronization with the R&D tax credit statutes (Section 280C(c)), which might necessitate R&D credit reduction.
Interconnections with Other Tax Provisions
The revamped R&E expensing directives considerably intersect with other Tax Code facets, notably net operating losses (NOL), bonus depreciation, business interest expense limitations, and international taxation for major corporations. Holistic consideration of these elements is crucial. When embodying these provisions, taxpayers should simulate various scenarios while assessing the implications of alternate tax deductions available in 2025. These rejuvenated deductions could substantially lower regular tax obligations, fostering strategic planning prospects for taxpayers.
Accounting Adjustment - The transitional regulations are treated as an automatic accounting change, streamlining compliance. This deduction "catch-up" opportunity provides a notable cash flow lifeline for affected firms, offering prompt reprieve from prior capitalization prerogatives. The IRS furnished preliminary guidance through Rev Proc 2025-28 on effectuating the change by annexing a statement to their return rather than submitting Form 3115, Application for Change in Accounting Method.
Engage with our firm to model these options meticulously and chart the optimal strategy, as these selections may bear on additional tax provisions such as Net Operating Loss (NOL) guidelines and business interest expense confinements.
Sign up for our newsletter.
Each month, we will send you a roundup of our latest blog content covering the tax and accounting tips & insights you need to know.
We care about the protection of your data.